Word: co-author
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Parents also must be educated. According to Lynnda Dahlquist, a professor at the University of Maryland, Baltimore County, and co-author of the chronic-pain chapter in the Handbook of Pediatric Psychology (2003), many parents reinforce avoidance behavior in kids with chronic pain by doing something that comes naturally to parents: being kind to their kids. "Let's say Johnny's back pain flares up during math class," says Dahlquist. "He feels terrible, so he says, 'I can't do my math.' Mom comes, takes him home, puts the TV on and gives him a back rub. Well, math...
...emergence of the resistant strain, health officials might have recommended that clinicians restrict prescriptions of the drug. Instead, it appears that the drug-resistant strain mutated on its own. "Flu viruses mutate all the time," says Dr. Alicia Fry, a medical epidemiologist at the CDC and a co-author of the study. "We suspect this is just one of those spontaneous mutations that occurred and is not related to overuse of the drug...
...visit to the Middle East this week, the prospects for peace are bleak. But Shibley Telhami, a professor of political science at the University of Maryland and a leading U.S.-based authority on Arab-Israeli negotiations, tells TIME that a deal remains within reach. Clinching that deal, says Telhami, co-author of a new report on the U.S.'s role in the peace process for the Brookings Institution and the Council on Foreign Relations, requires urgent action by the U.S. because time is running out on the two-state option...
...preserve cost-benefit analysis as a tool, but not to use it in such a way as to always reach the conclusion that regulation is too costly to impose. "It's true that cost-benefit analysis has been used in a very anti-regulatory way," says Michael A. Livermore, co-author, with Richard L. Revesz, of Retaking Rationality: How Cost-Benefit Analysis Can Better Protect the Enviroment and Our Health. "But cost-benefit analysis can be fixed to be more of a neutral tool." And in the midst of a severe economic downturn, he says, "it's going...
...published in the current issue of Nature Structural & Molecular Biology, they did not mutate at all. "If we use this approach judiciously, we should be able to keep this pocket conserved and not develop drug resistance to it," says Dr. Wayne Marasco of the Dana Farber Cancer Institute, a co-author of the paper. "The exciting part is that this is really a therapy that can be used for prophylaxis and treatment...